Holen Sie sich die Stockscreener-App
18.52
1.65%
0.30
Schlusskurs vom Vortag:
$18.22
Offen:
$18.18
24-Stunden-Volumen:
268.25K
Relative Volume:
0.53
Marktkapitalisierung:
$771.00M
Einnahmen:
Nettoeinkommen (Verlust:
KGV:
-
EPS:
-
Netto-Cashflow:
1W Leistung:
-13.90%
1M Leistung:
-34.05%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$17.38
$22.11
52-Wochen-Spanne:
$16.12
$35.29
Apnimed, Inc. Common Stock Stock (APMD) Company Profile
Firmenname
Apnimed, Inc. Common Stock
Sektor
Branche
Telefon
-
Adresse
-
Compare APMD vs VRTX, MRNA, REGN, ARGX, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
APMD
Apnimed, Inc. Common Stock
|
18.52 | 771.00M | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
510.08 | 129.29B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
225.00 | 89.83B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
746.54 | 76.86B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
825.03 | 51.88B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
189.76 | 40.67B | 742.00K | -1.37B | -1.07B | -7.0731 |
Apnimed, Inc. Common Stock Stock (APMD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-08-25 | Eingeleitet | BofA Securities | Buy |
| 2026-08-25 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2026-08-25 | Eingeleitet | Evercore ISI | Outperform |
Apnimed, Inc. Common Stock Aktie (APMD) Neueste Nachrichten
Apnimed, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Apnimed, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Apnimed (APMD) CEO Lind logs large stock option reclassification and vesting terms - Stock Titan
Apnimed, Inc. (APMD) Company Information - Simply Wall Street
Apnimed (APMD) Stock Price, News & Analysis - Stock Titan
Apnimed Announces Pricing of Upsized Initial Public Offering - PR Newswire
Apnimed prices IPO at $16 per share, raising $192 million - Investing.com
Apnimed closes upsized IPO, raising $220.8 million - scanx.trade
Apnimed prices IPO at $16 per share, raising $192 million - Investing.com
Apnimed Seeks IPO For OSA Treatment Commercialization (APMD) - Seeking Alpha
S-1 - SEC.gov
Upcoming and recent IPOs – IPOs calendar - Yahoo Finance Australia
Finanzdaten der Apnimed, Inc. Common Stock-Aktie (APMD)
Es liegen keine Finanzdaten für Apnimed, Inc. Common Stock (APMD) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
Apnimed, Inc. Common Stock-Aktie (APMD) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| SEKHRI PAUL J | Director |
Aug 03 '26 |
Buy |
16.00 |
12,500 |
200,000 |
12,500 |
3.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):